三友医疗 (688085.SH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	549.9M	542.8M	453.6M	460.4M	649.2M
Cost of Revenue	139.4M	136.2M	130.0M	92.3M	63.8M
Gross Profit	410.5M	406.6M	323.6M	368.1M	585.4M
Operating Expenses
R&D Expense	85.0M	83.7M	84.3M	65.2M	60.4M
SG&A Expense	—	—	—	—	—
General & Admin Expense	69.6M	67.7M	67.2M	32.0M	36.7M
Selling & Marketing Expense	189.6M	177.4M	144.5M	161.5M	297.0M
Other Expenses	—	—	—	—	—
Total Operating Expenses	348.2M	328.0M	292.8M	248.6M	392.6M
Cost and Expenses	487.6M	464.2M	422.9M	340.9M	456.4M
Operating Income (EBIT)	39.7M	51.0M	21.1M	120.4M	229.1M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	43.9M	55.2M	21.9M	134.9M	239.5M
Income Tax Expense	7.5M	10.3M	9.8M	21.2M	36.0M
Bottom Line
Net Income	57.3M	63.1M	11.5M	95.6M	190.8M
Earnings from Cont. Ops	36.4M	44.9M	12.1M	113.6M	203.6M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	57.3M	63.1M	11.5M	95.6M	190.8M
Per Share
Basic EPS	CN¥0.17	CN¥0.19	CN¥0.04	CN¥0.38	CN¥0.77
Diluted EPS	CN¥0.17	CN¥0.19	CN¥0.04	CN¥0.38	CN¥0.77
Revenue Per Share	CN¥1.56	CN¥1.63	CN¥1.58	CN¥1.83	CN¥2.62
Shares
Basic Shares Outstanding	352.8M	332.1M	286.7M	251.5M	247.8M
Diluted Shares Outstanding	352.8M	332.1M	286.7M	251.5M	247.8M
Profitability Metrics
EBITDA	—	103.9M	75.8M	170.6M	259.7M
D&A	—	52.9M	54.8M	50.2M	30.6M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026